通过导管干预,以使用TriClip来管理三体吐
Anmol Sharedalal1, Alexandra Zois1, Parija Sharedalal2
1From the Department of Medicine, St. Georges University, Grenada, West Indies.
Cardiology in review
|June 27, 2024
概括
严重的三回 (TR),影响数百万,往往缺乏有效的治疗. 使用TriClip设备进行跨导管端到端的修复提供了一个安全的,新的选择,以提高生活质量.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 心脏外科手术 心脏外科手术
背景情况:
- 严重的三回 (TR) 是一种普遍的心脏病,影响全球超过7000万人.
- 目前的管理策略,主要是尿液治疗,提供有限的死亡率益处.
- 对于传统的手术干预来说,TR的主要或次要的原因对传统的手术干预构成了重大挑战.
研究的目的:
- 审查严重三腹吐 (TR) 的管理.
- 提供跨导管边缘到边缘修复 (TEER) 的概述,作为严重TR的治疗选择.
- 具体讨论用于TR管理的TriClip设备的应用和结果.
主要方法:
- 关于三腹的管理现有文献的审查.
- 专注于严重TR的跨导管干预.
- 对TriClip设备 (Abbott) 的详细检查,用于跨导管边缘到边缘修复.
主要成果:
- 过导管干预措施在治疗严重的TR时显示出安全性和有效性.
- 这些新的方法可以减少TR的严重程度,并改善患者的生活质量.
- 该TriClip设备代表了微创性TR治疗的重大进步.
结论:
- 过导管边缘到边缘修复是一种可行的和有效的治疗严重的TR.
- 该TriClip设备为患有复杂心脏结构和TR的患者提供了一个有前途的解决方案.
- 最少侵入性技术正在改变以前服务不足的TR患者的管理.
相关概念视频
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Regurgitation IV: Nursing Management
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Pericarditis III: Medical Management
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...


